Related Experiment Video
Updated: Jul 2, 2026
15:07
VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
Bcl-2 expression in Hodgkin's lymphoma progression.
Corina Flangea1, Elena Potencz, Rodica Mihăescu
1Biochemistry Department, Victor Babeş University of Medicine and Pharmacy, Timisoara, Romania. flangeacorina@yahoo.com
Summary
Bcl-2 expression in Hodgkin
Area of Science:
- Oncology
- Hematology
- Immunohistochemistry
Background:
- Hodgkin's lymphoma diagnosis and staging are critical for treatment.
- Immunohistochemical analysis of Bcl-2 protein expression offers insights into disease progression.
Purpose of the Study:
- To investigate the correlation between Bcl-2 expression in tumor cells and the stage of classical Hodgkin's lymphoma.
- To assess the utility of Bcl-2 immunohistochemistry for improving disease staging and guiding therapeutic decisions.
Main Methods:
- Sixty-three classical Hodgkin's disease cases were analyzed.
- Histopathological diagnosis was confirmed using standard staining methods.
- Immunohistochemical staining for Bcl-2 expression was performed on tumor cells.
Main Results:
- A significant direct correlation was observed between increased Bcl-2 expression and advanced disease stages (III and IV) (p < 0.001).
- Early stages (I and II) showed lower Bcl-2 expression levels (-/+).
- No significant association was found between Bcl-2 expression and histological subtypes.
Conclusions:
- Bcl-2 expression levels correlate with Hodgkin's lymphoma stage, potentially aiding in accurate staging.
- Cases with higher Bcl-2 expression initially staged as I or II warrant re-evaluation.
- Immunohistochemistry for Bcl-2 is a valuable tool for refining staging and therapeutic strategies in Hodgkin's lymphoma.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:24B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
01:23Cells of the Adaptive Immune Response
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...